While there is no cure for HIV, we're committed to meeting the needs of patients and helping improve the lives of the 37.7 million people living with HIV around the world and the many more at risk for HIV.

Grant Funding Through the Zeroing In program, Gilead has awarded $24 million in grants to help reduce health disparities, improve access to quality healthcare, advance medical education and support local communities most impacted by the HIV epidemic and COVID-19 pandemic.

Today, a generation of expensive Gilead drugs containing the new iteration of tenofovir account for half of the market for H.I.V. treatment and prevention, according to IQVIA, an industry data provider. One widely used product, Descovy, has a sticker price of $26,000 annually.

In a new 60-second commercial launched just before Christmas and sponsored by HIV and AIDS drug maker Gilead, we see American actor, Tony Award winner and HIV patient André De Shields sitting directly in front of the camera saying simply: “HIV is not crime.”

Gilead's therapeutic areas of focus include HIV/AIDS, liver diseases, hematology and oncology, inflammatory and respiratory diseases and cardiovascular conditions.

Gilead was conceived by a group called the Sons of Jacob, comprised of men and women united by the goal of "[wanting] to set things right [and] clean up this country," as an early member explained in the show.

A jury cleared Gilead Sciences of U.S. government allegations that it violated patents held by the Centers for Disease Control and Prevention on an HIV prevention drug. The government had sued Gilead in 2019 arguing that the company was profiting off CDC patents through the company's sales of Truvada and Descovy.

The case centered on allegations that the defendants fraudulently enrolled people in Gilead's access program and then resold the company's free PrEP drugs. The company claimed it was swindled out of tens of millions of dollars through the fraud web.

The U.S. Food and Drug Administration approved Gilead's Truvada for HIV prevention in 2012 and approved its related drug Descovy for the same purpose in 2019. Gilead made more than $2 billion last year from worldwide sales of Truvada and Descovy, according to a company report.

In a new 60-second commercial launched just before Christmas and sponsored by HIV and AIDS drug maker Gilead, we see American actor, Tony Award winner and HIV patient André De Shields sitting directly in front of the camera saying simply: “HIV is not crime.”

Gilead's primary areas of focus include HIV/AIDS, liver diseases, serious respiratory and cardiovascular conditions, cancer and inflammation.

Gilead was the scene of the battle between Gideon and the Midianites and was also the home of the prophet Elijah.